Expression of MUC1, Thomsen-Friedenreich antigen, Tn, sialosyl-Tn, and α2,6-linked sialic acid in hepatocellular carcinomas and preneoplastic hepatocellular lesions

Virchows Archiv

Volumn 434, Issue 6, 1999, Pages 503-509

  Cao, Yi ^a   Karsten, Uwe ^b   Otto, Gerd ^c   Bannasch, Peter ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^c Deutsches Krebsforschungszentrum ^*

Author keywords

Carbohydrates; Cytokeratin; Liver; Mucin; Thomsen Friedenreich related antigens

Indexed keywords

ANTIGEN; CYTOKERATIN; MUCIN; SIALIC ACID;

ARTICLE; BILE DUCT CARCINOMA; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; NORMAL HUMAN; PRECANCER; PRIORITY JOURNAL;

ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CA-15-3 ANTIGEN; CARCINOMA, HEPATOCELLULAR; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LIVER NEOPLASMS; N-ACETYLNEURAMINIC ACID; PRECANCEROUS CONDITIONS;

EID: 0033044670     PISSN: 09456317     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004280050375     Document Type: Article

References (35)

1. 1. Abenoza P, Manivel JC, Wick MR, Hagen K, Dehner LP (1987) Hepatoblastoma: an inimunohistochemical and ultrastructural study. Hum Pathol 18:1025-1035
2. 2. Bannasch P, Jahn U-R, Hacker HJ, Su Q, Hofmann W, Pichlmayr R, Otto G (1997) Focal hepatic glycogenosis: a putative preneoplastic lesion associated with neoplasia and cirrhosis in explanted human livers. Int J Oncol 10:261-268
3. 3. Cao Y, Karsten U, Liebrich W, Haensch W, Springer GF, Schlag PM (1995) Expression of Thomsen-Friedenreich-related antigens in primary and metastatic colorectal carcinomas: a reevaluation. Cancer 76:1700-1708
4. 4. Cao Y, Stosiek P, Springer GF, Karsten U (1996) Thomsen-Friedenreich-related carbohydrate antigens in normal adult human tissues: a systematic and comparative study. Histochem Cell Biol 106:197-207
5. 5. Cao Y, Blohm D, Ghadimi BM, Stosiek P, Xing P-X, Karsten U (1997) Mucins (MUC1 and NUC3) of gastrointestinal and breast epithelia reveal different and heterogeneous tumor-associated aberrations in glycosylation. J Histochem Cytochem 45:1547-1557
6. 6. Cao Y, Schlag PM, Karsten U (1997) Immunodetection of epithelial mucins (MUC1, MUC3) and mucin-associated glycotopes (TF, Tn, and sialosyl-Tn) in benign and malignant lesions of colon epithelium: apolar localization corresponds to the malignant transformation. Virchows Arch 431:159-166
7. 7. Gibson JB, Sobin LH (1978) Histological typing of tumours of the liver, biliary tract and pancreas. (International histological classification of tumours, no 20) WHO, Geneva
8. 8. Gum JR Jr (1995) Human mucin glycoproteins: varied structures predict diverse properties and specific functions. Biochem Soc Trans 23:795-799
9. 9. Hilkens J, Wesseling J, Vos HL, Storm J, Boer B, van der Valk SW, Mass MCE (1995) Involvement of the cell surface-bound mucin, episialin/MUC1, in progression of human carcinomas. Biochem Soc Trans 23:822-826
10. 10. Ho SB, Niehans GA, Lyftogt C, Yan PS, Cherwitz DL, Gum ET, Dahiya R, Kim YS (1993) Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res 53:641-651
11. 11. Jass JR, Allison LJ, Edgar SG (1994) Monoclonal antibody TKH2 to the cancer-associated epitope sialosyl Tn shows cross-reactivity with variants of normal colorectal goblet cell mucin. Pathology 26:418-422
12. 12. Karsten U, Papsdorf G, Roloff G, Stolley P, Abel H, Walther I, Weiss H (1985) Monoclonal anti-cytokeratin antibody from a hybridoma clone generated by electrofusion. Eur J Cancer Clin Oncol 21:733-740
13. 13. Karsten U, Butschak G, Cao Y, Goletz S, Hanisch FG (1995) A new monoclonal antibody (A78G/A7) to the Thomsen-Friedenreich pan-tumor antigen. Hybridoma 14:37-44
14. 14. Kew MC (1997) Clinical and nonimaging diagnosis of hepatocellular carcinoma. In: Okuda K, Tabor E (eds) Liver cancer. Churchill Livingstone, New York, pp 315-329
15. 15. Kim YS, Gum JR Jr, Brockhausen I (1996) Mucin glycoproteins in neoplasia. Glycoconjugate J 13:693-707
16. 16. Kojiro M (1997) Pathology of hepatocellular carcinoma. In: Okuda K, Tabor E (eds) Liver cancer. Churchill Livingstone, New York, pp 165-187
17. 17. Lloyd KO, Burchell J, Kudryashov V, Yin BWT, Taylor-Papadimitriou J (1996) Comparison of O-linked carbohydrate chains in MUC1 mucin from normal breast epithelial cell lines and breast carcinoma cell lines. J Biol Chem 52:33325-33334
18. 18. Ma CK, Zarbo RJ, Frierson HF, Lee MW (1993) Comparative immunohistochemical study of primary and metastatic carcinomas of the liver. Am J Clin Pathol 99:551-557
19. 19. Marer NL, Stehelin D (1995) High alpha-2,6-sialylation of N-acetyllactosamine sequences in ras -transformed rat fibroblasts correlates with high invasive potential. Glycobiology 2:219-226
20. 20. Morgenthaler J, Kemmner W, Brossmer R (1990) Sialic-acid-dependent cell adhesion to collagen IV correlates with in vivo tumorigenicity of the human colon-carcinoma sub-lines HCT116a and HCT116b. Biochem Biophys Res Commun 171:860-866
21. 21. Murakami I, Sarker AB, Hayashi K, Akagi T (1992) Lectin binding patterns in normal liver, chronic active hepatitis, liver cirrhosis, and hepatocellular carcinoma: an immunohistochemical and immunoelectron microscopic study. Acta Pathol Jpn 42:566-572
22. 22. Otsuka K, Mizuno M, Kagawa K, Kashima K, Ohkuma S (1992) Presence of a Vicia unijuga lectin-binding (Vgu) glycoprotein with Thomsen-Friedenreich (T) activity and Vgu glycoproteins in human primary hepatocellular carcinoma. Int J Biochem 24:1407-1419
23. 23. Rinderle SJ, Goldstein IJ, Matta KI, Ratcliffe RM (1989) Isolation and characterization of amaranthin, a lection present in the seeds of Amaranthus caudatus, that recognizes the T-(or cryptic T)-antigen. J Biol Chem 264:16123-16131
24. 24. Sachs L (1992) Angewandte Statistik, 7th edn. Springer, Berlin Heidelberg New York
25. 25. Sasaki M, Nakanuma Y, Terada T, Kim YS (1995) Biliary epithelial expression of MUC1, MUC2, MUC3, and MUC5/6 apomucins during intrahepatic bile duct development and maturation: an immunohistochemical study. Am J Pathol 147:574-579
26. 26. Shibuya N, Goldstein IJ, Broekaert WF, Nsimba-Lubaki M, Peeters B, Peumans WJ (1987) The elderberry (Sambucus nigra L.) bark lectin recognizes the Neu5Ac(α2-6)Gal/GalNAc sequence. J Biol Chem 262:1596-1601
27. 27. Stosiek P, Kasper M, Karsten U (1990) Expression of cytokeratin 19 during human liver organogenesis. Liver 10:59-63
28. 28. Su Q, Benner A, Hofmann WJ, Otto G, Pichlmayr R, Bannasch P (1997) Human hepatic preneoplasia: phenotyes and proliferation kinetics of foci and nodules of altered hepatocytes and their relationship to liver cell dysplasia. Virchows Arch 431:391-406
29. 29. Su Q, Zerban H, Otto G, Bannasch P (1998) Cytokeratin expression is reduced in glycogenotic clear hepatocytes but increased in ground glass cells in chronic human and woodchuck hepadnaviral infection. Hepatology 28:347-359
30. 30. Taylor-Papadimitriou J, Epenetos AA (1994) Exploiting altered glycosylation patterns in cancer: progress and challenges in diagnosis and therapy. Trends Biotechnol 12:227-233
31. 31. Vandenhaute B, Buisine M-P, Debailleul V, Clement B, Moniaux N, Dieu M-C, Degand P, Porchet N, Aubert J-P (1997) Mucin gene expression in biliary epithelial cells. J Hepathol 27:1057-1066
32. 32. Vavasseur F, Dole K, Yang J-M, Matta KL, Myerscough N, Corfield A, Paraskeva C, Brockhausen I (1994) O-Glycan biosynthesis in human colorectal adenoma cells during progression to cancer. Eur J Bichem 22:415-424
33. 33. Xiang P-X, Prenzoska J, Layton GT, Devine PL, McKenzie IFC (1992) Second-generation monoclonal antibodies to intestinal MUC2 peptide reactive with colon cancer. J Natl Cancer Inst 84:699-703
34. 34. Yamashita K, Yonezawa S, Tanaka S, Shirahama H, Sakoda K, Imai, Xing P-X, McKenzin IFC, Hilkens J, Kim YS, Sato E (1993) Immunohistochemical study of mucin carbohydrates and core proteins in hepatolithiasis and cholangiocarcinoma. Int J Cancer 55:82-91
35. 35. Zhang SM, Wu M, Chen H, Zhang X (1989) Changes of glycoconjugates in human hepatocellular carcinoma. Histochemistry 92:171-175